REGN News

Pomerantz LLP Informs Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN

Regeneron Pharmaceuticals, Inc. (REGN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 14, 2026

Pomerantz LLP Issues Reminder to Investors in Regeneron Pharmaceuticals, Inc. of Class Action Filing – REGN

Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Represents Shareholders

Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman

The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN

Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Represents Shareholders

Pomerantz LLP Notifies Investors of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!